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Summary Relationships between incidence of Wilms' tumour and information recorded at birth were
investigated in a prospective study of the 1 489 297 children born in Norway between 1967 and 1992. A total
of 119 individuals were diagnosed with Wilms' tumour in the age interval 0-14 years. A high length at birth
was significantly associated with a high risk (incidence rate ratio 1.8 for length >53 cm vs .49 cm, 95% CI
1.0-3.2). A low Apgar score at 1 min was also associated with an increased risk (incidence rate ratio 2.2 for
Apgar score .8 vs a score >9, 95% CI 1.2-3.9). For all variables for which an association was indicated, the
association seemed to be restricted mainly to children aged less than 2 years. This suggests that Wilms' tumour
diagnosed early in life may differ aetiologically from that of cases diagnosed later.
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Wilms' tumour is an embryonic tumour of the kidney and the
majority of cases are diagnosed in early childhood (Breslow
et al., 1988). A recent study of the histology of Wilms'
tumour (Beckwith et al., 1990) showed that the tumour is
generally composed of metanephric blastemal cells at various
stages of differentiation. For a normal kidney to develop,
differentiation of such cells must occur without interruption
between weeks 5 and 35 ofgestation (Potter, 1972). Thus, the
persistence of undifferentiated cells suggests that a distur-
bance occurred in the development of the kidney during this
period in patients with Wilms' tumour.
Certain paternal occupations have been implicated in the
Getiology of Wilms' tumour but the evidence is not
conclusive (Breslow et al., 1993). Relations have also been
explored with environmental and gestational variables and
birth characteristics to ascertain factors which might
predispose the fetus to the development of Wilms' tumour
(Bunin et al., 1987; Lindblad et al., 1992; Olshan et al., 1993).
No final conclusions, however, can yet be drawn.
This paper investigates relations between birth character-
istics and incidence of Wilms' tumour in a population-based
prospective study. Particular attention is paid to the strength
of the potential associations in the separate age groups less
than 2 and 2- 14 years.
Materials and methods
The study population includes all 1 489 297 children born in
Norway between 1967 and 1992. Registration with the
Medical Birth Registry of Norway has been a legal
requirement since 1967. A standard form, recording
information about the birth and pregnancy, is completed by
the midwife at the time of birth. The information includes
birth date, sex, birth weight, length and vital status of the
infant, Apgar score at 1 and at 5 min and any obvious birth
defects or congenital malformations. The birth order of the
infant is reported by the mother. Information is also recorded
on the duration of the pregnancy, health problems of the
mother before and during pregnancy, procedures used during
delivery, use of analgesics etc., and demographic character-
istics of the parents.
On the basis of the unique personal identification numbers
used in Norway, the information from the Medical Birth
Registry was linked to files from the Cancer Registry of
Norway. Since 1953, all cases of cancer diagnosed in Norway
must be reported to the Cancer Registry. For each child
included in this study, the follow-up period extended from
the date of birth until the child attained either the age of
15 years or the final date of follow-up, 31 December 1993; or
was diagnosed with Wilms' tumour, or died of any cause.
The follow-up comprised a total of 16 607 130 person-years,
with a mean follow-up time per child of 11.2 years. The cases
considered in this paper represent the 119 live-born children
who were diagnosed during the follow-up with a histologi-
cally confirmed Wilms' tumour (ICD seventh revision site
code 180.0). None of the cases had been diagnosed with the
rare birth defects, aniridia, Beckwith-Wiedemann syndrome
or hemihypertrophy, which can be associated with Wilms'
tumour (Beckwith et al., 1990).
Log-linear Poisson regression analysis, taking into account
the period of follow-up for each child in separate age
categories (Breslow and Day, 1987), was used to investigate
associations between variables recorded in the Medical Birth
Registry and the incidence of Wilms' tumour. The
computations were performed using the program package
Epicure (Preston et al., 1993). Adjustment was made for sex
and age, with 1-year categories until the age of 6 years and a
combined category for the low-risk age group 6-14 years. In
view of the heterogeneity in the pathology ofWilms' tumour,
with different subtypes tending to predominate among
younger or older patients (Beckwith et al., 1990; Breslow et
al., 1993), the age intervals 0-1 years and 2- 14 years were
also analysed separately. Likelihood ratio tests for differences
in risk were based on the regression analyses. Certain
analyses included only a subset of the complete data set as
the potential risk factor involved had not been recorded for
all children in the Medical Birth Registry. The relevant
number of cases in each risk category is given in the tables.
Results
The risk of Wilms' tumour was strongly associated with the
age of the child (Table I). A peak in risk was seen in the
bimodal age distribution during the second year, with a much
lower peak in the fifth year. The risk declined sharply after
the sixth year.
A total of 63 boys and 56 girls were diagnosed with
Wilms' tumour. The median age at diagnosis was 26 months
for boys and 35 months for girls. The rate ratio for boys vs
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estimates were higher for boys than for girls during the first
two years, with a reversed relationship at higher ages. A test
for interaction between sex and age (considering the broad
categories 0-23 months and >24 months) was marginally
significant (P =0.086).
Higher risk estimates were found with increasing
gestational age (Table II), although no statistically signifi-
cant relation could be established. Birth weight showed no
clear overall association with risk of Wilms' tumour, despite
an indication that infants weighing more than 4000 g at birth
carried a slightly increased risk. In contrast, children who
were 52 cm or longer at birth had a significantly elevated risk
(Table II). Risk estimates for length were essentially
unchanged by adjustment for birth weight, while associa-
tions suggested for birth weight were weakened by
adjustment for length (results not shown). Infants with an
Apgar score at 1 min of 8 or less carried a 2-fold risk of
Wilms' tumour. Similar, but not as marked, results were
obtained for Apgar score at 5 min [with an incidence rate
ratio (IRR) of 1.49 for a score of <9 vs> 10, 95% CI 0.81 -
2.72]. The relation with Apgar score was unaffected by
further adjustment for body weight or length. Neither
mother's age nor father's age were associated with risk of
Wilms' tumour (Table II). No association was found with
birth order (IRR= 1.01 for birth order >2 vs < 1, 95% CI
0.66- 1.54) or time since previous birth for the mother
(IRR=0.86 for >24 months vs .24 months, 95% CI 0.45-
1.66).
The estimated rate ratio for Wilms' tumour for children
with complications during birth reported for placenta,
amniotic fluid or umbilical cord was 1.03 (95% CI 0.67-
1.58), with all children without any reports of such
complications as the reference group. The corresponding
rate ratio for complications at birth involving the fetus was
0.78 (95% CI 0.38-1.61), for anaesthetics used at birth 0.71
(95% CI 0.40-1.27), for induced birth 0.94 (95% CI 0.56-
1.60), and for complications at birth involving the mother
0.91 (95% CI 0.51-1.62). Infants, whose mothers reported
problems with their health during pregnancy, had a rate ratio
of 0.89 (95% CI 0.50-1.58).
Table III gives results of analyses of potential linear
relations between risk of Wilms' tumour and the variables
gestational age, birth weight, length and Apgar score at
1 min. The results are given separately for the age groups
<24 and> 24 months, as well as for the entire age range.
For each variable considered, a stronger linear association
was found for children aged less than 24 months. For both
length and Apgar score at 1 min, the associations were
statistically significant among the very young children but not
in the higher age group. For birth weight, an increased risk
was found among children less than 24 months in the
particular category corresponding to weights above 4000 g
(IRR=2.21, 95% CI 1.02-4.81, compared with weights in
the interval 3001-3500 g, represented by 16 and 13 cases
respectively).
Table I Risk of Wilms' tumour by age, prospective study, Norway
1967- 1993
No. of Incidence ratea Incidence rate ratio
cases Total Males Females males vs females
Age (months)
0-11 22 14.9 18.5 11.1 1.66
12-23 26 18.0 21.6 14.2 1.52
24-35 23 16.6 16.9 16.3 1.04
36-47 10 7.6 4.4 10.9 0.41
48-59 15 11.9 10.8 13.0 0.83
60-71 11 9.1 8.1 10.2 0.79
72- 179 12 1.4 1.4 1.4 0.95
aPer 106 person - years
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Discussion
In this population-based prospective study involving perinatal
risk factors, the incidence of Wilms' tumour was found to be
associated with a high length at birth and a low Apgar score
Table II Risk of Wilms' tumour by birth characteristics, prospec-
tive study, Norway 1967-1993a
No. of Incidence rate ratio P-value
cases (with 95% CI) for trend
Gestational age (weeks) 0.20
<37 7 0.66 (0.29-1.50)
38-39 27 0.81 (0.49-1.35)
40 33 1.OOb
41-42 34 0.90 (0.56-1.45)
43 8 1.47 (0.68-3.18)
Birth weight (g) 0.22
<3000 12 0.63 (0.33- 1.20)
3001-3500 40 1.00b
3501-4000 33 0.78 (0.49-1.25)
>4000 24 1.19 (0.72-1.98)
Length (cm) 0.025
<49 26 100
50 24 1.39 (0.80-2.43)
51 22 1.43 (0.81-2.53)
52 22 1.81 (1.02-3.20)
>53 23 1.79 (1.01-3.16)
Apgar score at 1 min 0.022
K,7 7 2.15 (0.95-4.87)
8 11 2.20 (1.11-4.35)
9, 10 33 1.00
Mother's age at
birth (years) 0.97
<20 14 100
21-25 43 1.17 (0.64-2.13)
26-30 40 1.23 (0.67-2.27)
>31 22 1.03 (0.52-2.01)
Father's age at
birth (years) 0.29
<25 37
26-30 37 0.78 (0.49-1.23)
31-35 27 0.91 (0.55-1.50)
>36 11 0.65 (0.35- 1.23)
aResults adjusted for age and sex. bReference category.
TableIll Linear relations with incidence of Wilms' tumour, by age,
prospective study, Norway 1967-1993a
P-valuefor
Incidence rate ratio linear
Linear Age group No. of (with 95% CI) based interaction
variable (years) cases on linear relationb with agec
Gestational 0.97
age 0-1 44 1.17 (0.88-1.55)
2-14 65 1.09 (0.87-1.38)
Total 109 1.12 (0.94-1.34)
Birth weight 0.09
0-1 44 1.30 (0.95-1.80)
2-14 65 1.03 (0.80-1.34)
Total 109 1.13 (0.93-1.38)
Length 0.027
0- 1 47 1.28 (1.05- 1.57)
2-14 70 1.07 (0.91-1.27)
Total 117 1.16 (1.02-1.31)
Apgar score 0.21
at 1 min 0-1 23 0.53 (0.33-0.88)
2-14 58 0.75 (0.45-1.28)
Total 51 0.64 (0.44-0.91)
aResults adjusted for age and sex. bIRR for comparing successive
levelsoflinearvariable, usingcategories showninTableII.cP-valuefor
linearchangein association, overallcategories ofage showninTableI.Birth characteristics and Wilms' tumour
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at 1 min. The associations were mainly restricted to children
aged less than 2 years. The study design eliminates selection
bias but the possibility of information bias should still be
considered for certain variables. The data from the Medical
Birth Registry are standardised but information may be
incomplete for variables such as structure of placenta or
description of the amniotic fluid. For this reason, only broad
groups were considered in the evaluation of risk for such
factors. The limited number of cases makes it difficult to
assess associations in subgroups of the data set. To increase
the statistical power, such analyses were mainly based on
potential linear relations among grouped observations.
The general age distribution of the cases is in agreement
with observations from other Western countries (Breslow et
al., 1993). The higher age at diagnosis in females than in
males is consistent with registry data from the United States
(Breslow et al., 1993), although the median age for each sex
seems to be lower in Norway. In contrast to the results of
Olson et al. (1993), based on a much larger data set, we
found no relation with parental age. However, because of the
age range (17-42 years for mothers and 18-46 years for
fathers of cases), we were not able to study associations with
the very high parental ages for which Olson et al. (1993)
found an increased risk.
No significant association was observed with birth weight
in our analyses including all children aged less than 15 years.
Similar results were found by MacMahon and Newill (1962),
Bunin et al. (1987), Lindblad et al. (1992) and Olshan et al.
(1993). Our risk estimates indicate, however, that children
under the age of 2 with a birth weight exceeding 4000 g may
carry an increased risk. This is in agreement with the results
of Daling et al. (1984), but not those of Bunin et al. (1987)
and Olshan et al. (1993).
In contrast to the results of Lindblad et al. (1992), we
found a statistically significant trend with an increasing risk
ofWilms' tumour over the whole range oflength measured at
birth. The association was particularly strong among children
with a diagnosis before the age of 2 years but largely
disappeared in the older age groups. Olshan (1986) suggested
that the high birth weight seen in some children with Wilms'
tumour might be related to an abnormal interaction of the
IGF-II (insulin-like growth factor II) gene and possibly the
insulin gene with the Wilms' tumour gene, WT1. Van
Heyningen and Hastie (1992) hypothesised that the maternal
allele loss at the second chromosome region IIpI5,
implicated in the development of Wilms' tumour, might be
associated with increased growth-promoting activity caused
by two parternally derived copies of IGF-II. These
hypotheses may also be relevant to the association seen
with high length. The maximum growth acceleration in terms
of fetal skeletal growth occurs around 16-18 weeks of
gestation (Tanner, 1978) and IGF-I and IGF-II are thought
to be important growth factors at this stage (Reece et al.,
1994).
In this study, no association was found with the
administration of anaesthetics during delivery. Thus, we are
unable to support the finding that administration of
penthrane during delivery is related to an increased risk of
Wilms' tumour (Lindblad et al., 1992). However, under-
reporting of use of anaesthetics to the Medical Birth Registry
may have influenced our risk estimate.
A high risk of Wilms' tumour was observed among
children with a lowered Apgar score at 1 min, with a similar
but weaker relation for Apgar score at 5 min. The Apgar
score was available only for a subset of the children
considered. The risk of Wilms' tumour among children with
a missing Apgar score at 1 min was intermediate (IRR= 1.56
compared with children with an Apgar score of 9 or 10).
Thus, it is difficult to see how any substantial bias in the
association with subsequent tumour diagnosis could be
introduced by under-reporting. The Apgar score is based
on evaluation of the newborn's heart rate, respiratory effort,
reflex ability, muscle tone and colour (Schmidt et al., 1988)
and a low score is in general an indicator of a stressed birth.
Since the relation with Apgar score was unaffected by
adjustment for birth weight and for length, it could reflect
an underlying developmental defect associated with Wilms'
tumour, especially in the cases diagnosed during the first 2
years of life.
More generally, however, associations in our data set
seemed to be restricted to Wilms' tumour diagnosed early in
life. There are several indications that the aetiology ofWilms'
tumour may differ between early and late cases, with a
change occurring at about 2-3 years of age (Beckwith et al.,
1990; Breslow et al., 1993). This may reflect disturbances in
the nephrogenic process occurring in different phases of
development (Pritchard-Jones and Hastie, 1990). With regard
to precursor lesions found in connection with Wilms' tumour,
cases with an early diagnosis tend in general to be associated
with intralobar nephrogenic rests, whereas a late diagnosis is
often associated with perilobar rests (Breslow et al., 1993).
The two types also tend to be associated with different kinds
of congenital anomalies (Beckwith et al., 1990). The relations
with perinatal risk factors seen in our data set may represent
the early type ofWilms' tumour, associated with disturbances
before week 14 during pregnancy (Pritchard-Jones and
Hastie, 1990), the end of the first phase in the development
of the kidney (Potter, 1972). In contrast, the later type may
have an aetiology which is not reflected in associations with
variables recorded at birth.
Assuming that an essential disturbance in the development
of the kidney took place before 14 weeks of gestation,
variables registered at birth are expected to shed information
on an event which happened at least 26 weeks earlier. In
order to collect more informative data on potential risk
factors during the pregnancy, we suggest that the relevant
earlier periods should be monitored with greater detail. For
the tumours diagnosed in older children, possibly other
environmental factors play a stimulating role in the
transformation from the susceptible state to the malignant.
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